Gene · 948
Papers3,971
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,971
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD36 deletion ameliorates diabetic kidney disease by restoring fatty acid oxidation and improving mitochondrial function. | Ren Fail | 2023 | 38097943 | PubTator, text mining | PubMed |
| Beneficial effects of Apelin-13 on metabolic diseases and exercise. | Front Endocrinol (Lausanne) | 2023 | 38089606 | PubTator, text mining | PubMed |
| Where the joy comes from: a qualitative exploration of deep GP-patient relationships. | BMC Prim Care | 2023 | 38087212 | PubTator, text mining | PubMed |
| Association between "cluster of differentiation 36 (CD36)" and adipose tissue lipolysis during exercise training: a systematic review. | Front Physiol | 2023 | 38074329 | PubTator, text mining | PubMed |
The Chemical Profile, Antioxidant, and Anti-Lipid Droplet Activity of Fluid Extracts from Romanian Cultivars of Haskap Berries, Bitter Cherries, and Red Grape Pomace for the Management of Liver Steatosis. | Int J Mol Sci | 2023 | 38069172 | PubTator, text mining | PubMed |
| Calpain and Cardiometabolic Diseases. | Int J Mol Sci | 2023 | 38069105 | PubTator, text mining | PubMed |
| Danlou Recipe promotes cholesterol efflux in macrophages RAW264.7 and reverses cholesterol transport in mice with hyperlipidemia induced by P407. | BMC Complement Med Ther | 2023 | 38066464 | PubTator, text mining | PubMed |
| Targeting dysregulated lipid metabolism in the tumor microenvironment. | Arch Pharm Res | 2023 | 38060103 | PubTator, text mining | PubMed |
| Unveiling P. vivax invasion pathways in Duffy-negative individuals. | Cell Host Microbe | 2023 | 38056460 | PubTator, text mining | PubMed |
| A review on the mechanisms underlying the antitumor effects of natural products by targeting the endoplasmic reticulum stress apoptosis pathway. | Front Pharmacol | 2023 | 38044941 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of Small-Molecule-Based Radioligands with Improved Pharmacokinetic Properties for Imaging of Programmed Death Ligand 1. | J Med Chem | 2023 | 38038981 | PubTator, text mining | PubMed |
| Phylogenetic and Protein Structure Analyses Provide Insight into the Evolution and Diversification of the CD36 Domain "Apex" among Scavenger Receptor Class B Proteins across Eukarya. | Genome Biol Evol | 2023 | 38035778 | PubTator, text mining | PubMed |
| Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review. | Front Pharmacol | 2023 | 38034996 | PubTator, text mining | PubMed |
| Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination. | Cureus | 2023 | 38024037 | PubTator, text mining | PubMed |
| 14 examples of how LLMs can transform materials science and chemistry: a reflection on a large language model hackathon. | Digit Discov | 2023 | 38013906 | PubTator, text mining | PubMed |
| Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment. | BMC Cancer | 2023 | 38012567 | PubTator, text mining | PubMed |
Development of Polycistronic Baculovirus Surface Display Vectors to Simultaneously Express Viral Proteins of Porcine Reproductive and Respiratory Syndrome and Analysis of Their Immunogenicity in Swine. | Vaccines (Basel) | 2023 | 38005998 | PubTator, text mining | PubMed |
| In Vivo and In Vitro Characterization of the Recently Emergent PRRSV 1-4-4 L1C Variant (L1C.5) in Comparison with Other PRRSV-2 Lineage 1 Isolates. | Viruses | 2023 | 38005910 | PubTator, text mining | PubMed |
| Naringenin Improves Innate Immune Suppression after PRRSV Infection by Reactivating the RIG-I-MAVS Signaling Pathway, Promoting the Production of IFN-I. | Viruses | 2023 | 38005850 | PubTator, text mining | PubMed |
| Intraductal Carcinoma of the Prostate: To Grade or Not to Grade. | Cancers (Basel) | 2023 | 38001579 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/948/papers?page=11